Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ji Hyung Hong, Doctor of Philoshophy
National Cancer Center, Korea
Principal Investigator - Jung Hun Kang, Doctor of Philoshophy
Gyeongsang National University Hospital
Principal Investigator - Keun Soek Lee, Doctor of Philoshophy
National Cancer Center, Korea
Principal Investigator - Seong Hoon Shin, Doctor of Philoshophy
Kosin University Gospel Hospital
Principal Investigator - Sujin Koh, Doctor of Philoshophy
Ulsan University Hospital
Principal Investigator - Sun Jin Sym, Doctor of Philoshophy
Gachon University Gil Medical Center
Principal Investigator - Sung Hoon Sim, Doctor of Philoshophy
National Cancer Center, Korea
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kosin University Gospel Hospital
Busan, South Korea
Recruiting - National Cancer Center, Korea
Goyang, South Korea
Recruiting - Gachon University Gil Medical Center
Incheon, South Korea
Not, yet, recruiting - Gyeongsang National University
Jinju, South Korea
Recruiting - Ulsan University Hospital
Ulsan, South Korea
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jul 2025
- Primary completion
- 31 Mar 2026
- Completion
- 30 Sept 2026
- Last update posted
- 12 Feb 2026
- Registered enrollment
- 414
- Registry id
- NCT07405931
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.